Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
Laboratory Automation & Robotics

Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases

Lana Keisha Mar 22, 2026 0

A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…

Read More
Advanced Materials Science

Cambridge Researchers Unveil Light-Driven Chemical Breakthrough to Accelerate Sustainable Drug Development

Nila Kartika Wati Mar 21, 2026 0

Researchers at the University of Cambridge have pioneered a transformative chemical technique that utilizes visible light to modify complex drug…

Read More
Clinical Diagnostics & Pathology

Clinical Laboratories Fortify Against Inevitable Disruptions, Prioritizing Sample Integrity and Sustained Operations Through Expert-Driven Strategies.

Reynand Amr Wu Mar 21, 2026 0

Clinical laboratories, the bedrock of modern healthcare diagnostics, face an increasingly complex array of potential disruptions that threaten their critical…

Read More
Advanced Materials Science

University of Cambridge Researchers Revolutionize Pharmaceutical Synthesis with Sustainable Light-Driven Chemical Reaction

Nila Kartika Wati Mar 14, 2026 0

In a landmark study published on March 12 in the journal Nature Synthesis, a team of researchers at the University…

Read More

Posts pagination

1 … 4 5
Scientists Identify Specific Brain Circuit Controlling Anxiety and Social Withdrawal and Successfully Reverse Symptoms in MiceOxford Professor Unveils AI Software Humatch for Rapid, Gene-Specific Antibody Humanization, Revolutionizing Therapeutic DevelopmentNeurobiological Underpinnings of Psychopathy: Examining the Link Between Striatal Enlargement and Antisocial BehaviorMixing evidence and imagination brings three real ancient Romans to life
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ